Breast cancer.
Conditions
Interventions
Intervention 1: Intervention group: experimental group : The 30 breast cancer patients(30 to 59 years) refer for treatment to SHafa Clinic in Bushehr in the experimental group underwent twelve w
Sponsors
Boushehr University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
30 Years to 59 Years
Inclusion criteria
Inclusion criteria: breast cancer diagnosis from oncologist. being at clinical stage I , II , or III no metastatic lesion. Age between 30 to 59 years ??At least 8 months after diagnosis and termination of acute treatment period such as surgery, chemotherapy, and radiation therapy which are effective in psycho-spiritual aspect and may have caused some bias in the study. having literacy having letter of satisfaction no history of psychotropic drug use, and no history of alcohol used or smoked during the 3 months before the study. no history of other neurosis or psychosis before diagnosis , such as depression and schizophrenia.. no history of other chronic diseases. no history of other cancer during 10 years. no history of psycho- spiritual education .
Exclusion criteria
Exclusion criteria: dissatisfaction to participate in research any disability to be present in sessions intervention those with history of cognitive disorder,confusion or cerebral injury.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Health Status. Timepoint: Study of Health Status at the beginning ,before intervention and after 12 weekly session( 3 month after Intervention) . Method of measurement: WHO Individual Questionnaire 2016.;Coping strategies. Timepoint: Study of Coping strategies at the beginning ,before intervention and after 12 weekly session( 3 month after Intervention) . Method of measurement: Lazarus & Folkman coping strategy questionnaire 1988.;Serum T Lymphocyte Immune System. Timepoint: Measure Serum T Lymphocyte Immune System at the beginning ,before intervention and after 12 weekly session( 3 month after Intervention). Method of measurement: 5 cc blood was obtained from participants & test analyzed by flow cytometry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZinab Hoossaini
Boushehr University of Medical Sciences
Outcome results
None listed